With another phase 3 win, Gilead races toward 2025 launch for long-acting PrEP drug 12.09.2024 18:15 Fiercepharma.com With another phase 3 win, Gilead races toward 2025 launch for long-acting PrEP drug zbecker Thu, 09/12/2024 - 11:15
